Supersapiens

Real-time biometric insights
Overview
Raised: $1,235,000
Rolling Commitments ($USD)
04/30/2023
$58,810
376
2019
Healthcare & Pharmaceuticals
HealthTech
B2B
Low
Low
Summary Profit and Loss Statement
FY 2021 | FY 2020 | |
---|---|---|
Revenue |
$1,832,611 |
$85,790 |
COGS |
$2,709,094 |
$201,991 |
Tax |
$1,517 |
$42 |
| ||
| ||
Net Income |
$-14,197,534 |
$-2,871,063 |
Summary Balance Sheet
FY 2021 | FY 2020 | |
---|---|---|
Cash |
$571,660 |
$86,084 |
Accounts Receivable |
$14,874 |
$0 |
Total Assets |
$5,125,416 |
$2,068,703 |
Short-Term Debt |
$2,151,423 |
$471,176 |
Long-Term Debt |
$14,294,462 |
$4,841,980 |
Total Liabilities |
$16,445,885 |
$5,313,156 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual